Download PDF. 1 / 3 Pages. Previous article. Go back to website. Next article. HARRIS D., Paul BRINCK M., Patricio. Un análisis retrospectivo de cavernomatosis de la vena porta en Chile: II. Hemorragia, tratamiento y pronóstico. Rev. chil. HARRIS D., Paul BRINCK M., Patricio. Un análisis retrospectivo de cavernomatosis de la vena porta en Chile.: I. Perfil clínico y de laboratorio. Rev. chil. pediatr.

Author: Jugami Mazugrel
Country: Gabon
Language: English (Spanish)
Genre: Education
Published (Last): 27 August 2012
Pages: 425
PDF File Size: 7.75 Mb
ePub File Size: 4.90 Mb
ISBN: 369-9-92175-645-5
Downloads: 76553
Price: Free* [*Free Regsitration Required]
Uploader: Gardadal

Thrombolytic treatment of portal thrombosis. Unfortunately, in practice, this policy is not applicable without difficulty.

J Cancer Res Clin Oncol. J Am Coll Surg. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. A retrospective analysis of cases and associated clinical implications. Kocher Porat, Himmelmann A. Mesenteric venous thrombosis to Value of CT and sonography in the conservative management of acute splenoportal and superior mesenteric venous thrombosis.

Although spontaneous resolution of PVT has been reported in the literature[], a specific therapeutic management is mandatory to resolve portal vein cavernoa and avoid serious complications. Report of a case.

Portal vein thrombosis: Insight into physiopathology, diagnosis, and treatment

Consider a diagnosis of chronic PVT in any patient with newly diagnosed portal hypertension. Consider a diagnosis of acute PVT in any patient with abdominal pain of more than 24 h duration, whether or not there is also fever or ileus.


Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. Thrombolytic therapy in patients with portal vein thrombosis: This article has been cited by other articles in PMC.

Furthermore, hypersplenism and, consequently, pancytopenia, are commonly present in chronic PVT[ 1 ]; however, if one branch of the portal vein ka preserved and the portal pressure is quite normal, they may even be absent.

Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Vascular complications after orthotopic liver transplantation.

Eversion thrombectomy for portal vein thrombosis during liver transplantation. Surgical restoration of portal cavrrnoma corrects procoagulant and anticoagulant deficiencies associated with extrahepatic portal vein thrombosis.

Complications of venous reconstruction in human orthotopic liver transplantation. Portal hypertension due to portal venous thrombosis: A gain-of-function mutation of JAK2 in myeloproliferative disorders. However, in case of long standing thrombosis, the management of complications related to portal hypertension and portal cholangiopathy has to be concurrently considered[ ].

Cavernoam mesenteric venous thrombosis: ;orta, for all these reasons and the good results reported in literature, today PVT has no longer to be considered a contraindication but only a disadvantage and, in some cases, might present a possible indication to liver transplantation[,].

Malformación cavernomatosa de la vena porta

Prevalence of potra risk factors in series of routinely investigated, consecutive adult patients with non tumorous and non cirrhotic, acute or chronic, PVT[ ]. Occasionally, it is not possible to recognize any overt cause of PVT; generally, the clinical course is favorable for these patients, with a low incidence of complications.


PVT is considered a milestone in the natural history of liver cirrhosis and it is related to serious complications, morbidity, and mortality, as previously discussed[ 87 ]. Portal vein grafts in hepatic transplantation.

Extrahepatic portal vein thrombosis. Portal vein thrombosis in children and adolescents.

There was a problem providing the content you requested

PVT can be classified cavernomw four categories, depending on the extension: Risk factors and clinical presentation of portal vein thrombosis se patients with liver cirrhosis. Male sex, previous treatment for PVT, Child-Pugh class C, and alcoholic liver disease might be associated with recurrence[ 85]. Hoekstra J, Janssen HL. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: Although in the general population PVT is considered a rare event, its prevalence among cirrhotic patients ranges between 4.